• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Faraday Future Intelligent Electric Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

    9/22/23 8:11:59 AM ET
    $AMTI
    $AVTX
    $BSFC
    $BWV
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMTI alert in real time by email

    Gainers

    GSE Systems, Inc. (NASDAQ:GVP) shares rose 32.4% to $0.4090 in pre-market trading after falling over 3% on Thursday.

    Roadzen (NASDAQ:RDZN) shares rose 23.4% to $8.11 in pre-market trading after falling more than 40% on Thursday.

    FLJ Group Limited (NASDAQ:FLJ) shares gained 20.3% to $0.3669 in pre-market trading.

    Blue Star Foods Corp. (NASDAQ:BSFC) shares rose 17.1% to $0.37 in pre-market trading. Blue Star Foods recently announced closing of $5 million public offering.

    Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares jumped 17% to $0.1199 in pre-market trading after falling 8% on Thursday. The company recently agreed to divest AVTX-800 series.

    Blue Water Biotech, Inc. (NASDAQ:BWV) rose 15.7% to $0.6494 in pre-market trading. Maxim Group recently downgraded Blue Water Biotech from Buy to Hold.

    Infobird Co., Ltd (NASDAQ:IFBD) shares surged 13% to $0.15 in pre-market trading. Infobird recently announced receipt of delinquency notification letter from Nasdaq.

    Solowin Holdings (NASDAQ:SWIN) rose 10.9% to $4.49 in pre-market trading after jumping 35% on Thursday.

    Tenon Medical, Inc. (NASDAQ:TNON) gained 9.4% to $0.1674 in pre-market trading. Tenon Medical recently announced expanded physician use of new JIB instrument kit for company's catamaran SI joint fusion system.

    Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares climbed 7.7% to $3.94 in pre-market trading as the company named Matthias Aydt as Global Chief Executive Officer, effective Sept. 29, 2023. The company also announced a management stock purchase plan.

    Losers

    Neptune Wellness Solutions Inc. (NASDAQ:NEPT) fell 41.5% to $2.34 in pre-market trading after the company reported pricing of $4.5 million public offering.

    Molekule Group, Inc. (NASDAQ:MKUL) shares fell 21.4% to $0.2678 in pre-market trading after dipping 19% on Thursday. Molekule Group recently announced in an 8K filing that the board authorized the management to commence preparation of voluntary petition under Chapter 11 of the U.S. Bankruptcy Code.

    Flux Power Holdings, Inc. (NASDAQ:FLUX) fell 19.4% to $3.99 in pre-market following weaker-than-expected quarterly sales.

    Applied Molecular Transport Inc. (NASDAQ:AMTI) fell 16.3% to $0.1708 in pre-market trading. Applied Molecular Transport agreed to merge with Cyclo Therapeutics Inc in an all-stock transaction.

    Scholastic Corporation (NASDAQ:SCHL) shares fell 16% to $32.72 in pre-market trading after the company reported downbeat results for its first quarter on Thursday.

    Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 15.7% to $1.78 in pre-market trading after jumping 26% on Thursday. Powerbridge Technologies expanded global trade digital platform services across Asia and Europe.

    CohBar, Inc. (NASDAQ:CWBR) shares fell 13.4% to $2.46 in pre-market trading.

    Pharming Group N.V. (NASDAQ:PHAR) fell 13.1% to $13.13 in pre-market trading after climbing around 15% on Thursday.

    Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 12.9% to $0.1363 in pre-market trading after gaining over 17% on Thursday.

    MDB Capital Holdings, LLC (NASDAQ:MDBH) fell 10.3% to $11.21 in pre-market trading. MDB Capital raised $19,999,992 and started trading on the NASDAQ on Sept. 21, 2023.

    Now Read This: Fear & Greed Index Moves To 'Fear' Zone After Dow Falls For Third Straight Session

    Get the next $AMTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTI
    $AVTX
    $BSFC
    $BWV

    CompanyDatePrice TargetRatingAnalyst
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Avalo Therapeutics Inc.
    $AVTX
    12/18/2025$39.00Outperform
    Mizuho
    Avalo Therapeutics Inc.
    $AVTX
    9/17/2025$15.00 → $25.00Buy
    H.C. Wainwright
    Avalo Therapeutics Inc.
    $AVTX
    9/5/2025Buy
    TD Cowen
    Scholastic Corporation
    $SCHL
    9/3/2025$37.00Buy
    B. Riley Securities
    Avalo Therapeutics Inc.
    $AVTX
    8/15/2025Overweight
    Cantor Fitzgerald
    Avalo Therapeutics Inc.
    $AVTX
    6/2/2025$15.00Buy
    H.C. Wainwright
    Avalo Therapeutics Inc.
    $AVTX
    3/25/2025$36.00Buy
    Stifel
    More analyst ratings

    $AMTI
    $AVTX
    $BSFC
    $BWV
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Avalo Therapeutics Inc.

    SCHEDULE 13G/A - Avalo Therapeutics, Inc. (0001534120) (Subject)

    2/17/26 6:13:19 PM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Avalo Therapeutics Inc.

    SCHEDULE 13G/A - Avalo Therapeutics, Inc. (0001534120) (Subject)

    2/17/26 4:21:21 PM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Avalo Therapeutics Inc.

    SCHEDULE 13G - Avalo Therapeutics, Inc. (0001534120) (Subject)

    2/17/26 4:11:55 PM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMTI
    $AVTX
    $BSFC
    $BWV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

    WAYNE, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the grant of inducement equity awards to two new employees. The Compensation Committee of the Board of Directors of Avalo approved the grants of nonstatutory stock options to purchase an aggregate of 82,000 shares of common stock (the "Options") as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The Options were granted on February 13, 2026 and have an exercise price of $14.

    2/18/26 4:05:00 PM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

    Leiden, the Netherlands, February 17, 2026: Pharming Group N.V. ("Pharming" or "the Company") (NASDAQ:PHAR) today announced its participation in the Oppenheimer 36th Annual Healthcare Life Sciences Conference being held virtually on February 25-26, 2026. Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, M.D., Chief Medical Officer, will present on Wednesday, February 25 at 12:40pm ET/18:40 CET. A live webcast and replay of the presentation will be made available in the "Upcoming Events" and "News" sections of Pharming's website. To schedule a one-on-one meeting with Pharming's management team, please contact Investor Relations at [email protected] or your Oppenheimer repres

    2/17/26 2:00:00 AM ET
    $PHAR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flux Power Reports Fiscal Year 2026 Second Quarter Financial Results

    VISTA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ:FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today reported financial and operational results for the 2026 fiscal second quarter ended December 31, 2025. Second Quarter and Recent Business Highlights Increased revenue 7.2% sequentially to $14.1 millionAchieved positive GAAP net income for the first time in its historySecured more than $3.6 million in additional purchase orders to support a long-standing airline customerAwarded U.S. Patent for determining the State of Health (SoH) of a battery pack, w

    2/12/26 4:05:00 PM ET
    $FLUX
    Industrial Machinery/Components
    Miscellaneous

    $AMTI
    $AVTX
    $BSFC
    $BWV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Avalo Therapeutics with a new price target

    Guggenheim initiated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $50.00

    2/2/26 6:51:00 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mizuho initiated coverage on Avalo Therapeutics with a new price target

    Mizuho initiated coverage of Avalo Therapeutics with a rating of Outperform and set a new price target of $39.00

    12/18/25 9:07:24 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    H.C. Wainwright reiterated coverage on Avalo Therapeutics with a new price target

    H.C. Wainwright reiterated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $25.00 from $15.00 previously

    9/17/25 11:38:46 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMTI
    $AVTX
    $BSFC
    $BWV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Founder Marlett Christopher A bought $4,246 worth of shares (1,213 units at $3.50), increasing direct ownership by 0.72% to 169,933 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    1/5/26 8:24:36 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    Co-Founder Marlett Christopher A bought $28,688 worth of shares (8,787 units at $3.26), increasing direct ownership by 6% to 166,720 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    12/31/25 4:34:29 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    President Brandon George Hugh bought $12,506 worth of shares (3,700 units at $3.38), increasing direct ownership by 4% to 105,248 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    12/11/25 7:59:02 AM ET
    $MDBH
    Finance: Consumer Services
    Finance

    $AMTI
    $AVTX
    $BSFC
    $BWV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Carlson Steven J. acquired 463,085 units of Ordinary Shares (SEC Form 4)

    4 - Roadzen Inc. (0001868640) (Issuer)

    2/19/26 4:05:20 PM ET
    $RDZN
    Specialty Insurers
    Finance

    Director Magennis Sean James was granted 10,000 shares, increasing direct ownership by 33% to 40,000 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    2/12/26 8:47:08 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    CFO James Jeremy William was granted 10,000 shares, increasing direct ownership by 50% to 29,839 units (SEC Form 4)

    4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

    2/12/26 8:44:10 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    $AMTI
    $AVTX
    $BSFC
    $BWV
    Leadership Updates

    Live Leadership Updates

    View All

    MDB Capital Holdings Announces Transitions In Its Board of Directors

    Addison, Texas, Feb. 02, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading "Big Idea" companies, today announced the appointment of Jeb Terry, Sr to its Board of Directors and extended its sincere gratitude to Susanne Meline as she concluded her dedicated and influential board service. Both transitions are effective as of February 1, 2026. Jeb Terry brings to the MDB board more than two decades of investment in microcap medical and biotechnology companies, where he has consistently identified and capitalized on high-potential opportunities in this dynamic and innovation-driven sector. He founded and s

    2/2/26 7:30:00 PM ET
    $MDBH
    Finance: Consumer Services
    Finance

    Scholastic Appoints Jeffrey Mathews as President of Scholastic Education, Adding to Current Role as Chief Growth Officer

    NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Scholastic Corporation (NASDAQ:SCHL), the global children's publishing, education and media company, today announced that Jeffrey Mathews has been appointed President, Scholastic Education, effective immediately, in addition to his current role as Executive Vice President and Chief Growth Officer. Based in New York, Mr. Mathews continues to report to Peter Warwick, Scholastic President and Chief Executive Officer. Scholastic Education advances Scholastic's mission by helping schools and educators address one of their most critical needs –

    1/5/26 9:30:00 AM ET
    $SCHL
    Books
    Consumer Discretionary

    Roadzen Announces Successful Closing of Its Acquisition of U.S. Commercial Auto Managing General Underwriter EliteCover

    NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (NASDAQ:RDZN) today announced the successful closing of its previously announced acquisition of majority control of EliteCover Insurance Solutions, Inc. ("EliteCover"), a licensed commercial auto insurance broker and managing general underwriter (MGU) operating across multiple U.S. states. First announced October 29, 2025, the acquisition strengthens Roadzen's position in the $80 billion in annual Gross Written Premiums (GWP) U.S. commercial auto insurance market by combining EliteCover's underwriting authority, regulatory licenses, and distribution footprint with Roadzen's AI, telematics, and automated claims capabilities. The tran

    12/3/25 8:00:00 AM ET
    $RDZN
    Specialty Insurers
    Finance

    $AMTI
    $AVTX
    $BSFC
    $BWV
    Financials

    Live finance-specific insights

    View All

    Flux Power Reports Fiscal Year 2026 Second Quarter Financial Results

    VISTA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ:FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today reported financial and operational results for the 2026 fiscal second quarter ended December 31, 2025. Second Quarter and Recent Business Highlights Increased revenue 7.2% sequentially to $14.1 millionAchieved positive GAAP net income for the first time in its historySecured more than $3.6 million in additional purchase orders to support a long-standing airline customerAwarded U.S. Patent for determining the State of Health (SoH) of a battery pack, w

    2/12/26 4:05:00 PM ET
    $FLUX
    Industrial Machinery/Components
    Miscellaneous

    Roadzen Reports Strongest Quarter in Two Years with $14.4 Million Third Quarter Revenue and Sixth Consecutive Quarter of Adjusted EBITDA Improvement

    Roadzen delivers 18.8% revenue increase and reduces operating loss by 25.4% over prior-year quarter Strategic wins, new contracts and acquisitions, expand Roadzen's U.S. market presence and full-stack operating capabilities, reinforcing its position as a global AI leader at the intersection of insurance and mobility Year-over-year Sequential Revenue Growth; Record Nine-Month RevenueQ3 revenue increased 18.8% over the prior-year quarter and 4.9% from Q2 to $14.4 million; nine-month revenue rose 18.3% to $38.9 million, marking a record nine months and Roadzen's best quarter in the last two years.Operating Loss Continue to Materially Decline; Sixth Consecutive Quarter of Adjusted EBITDA1 impr

    2/12/26 4:05:00 PM ET
    $RDZN
    Specialty Insurers
    Finance

    Flux Power to Host Fiscal Second Quarter 2026 Financial Results Conference Call on February 12, 2026

    VISTA, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ:FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, will report its fiscal second quarter 2026 results on Thursday, February 12, 2026, after market close. Krishna Vanka, Chief Executive Officer, and Kevin Royal, Chief Financial Officer, will host a conference call at 4:30 p.m. ET to discuss the Company's financial results, followed by a question-and-answer session. Analysts and investors are invited to join the conference call using the following information: Date: Thursday, February 12, 2026Time: 4:30 p.m.

    2/5/26 8:31:00 AM ET
    $FLUX
    Industrial Machinery/Components
    Miscellaneous

    $AMTI
    $AVTX
    $BSFC
    $BWV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Blue Star Foods Corp.

    SC 13G/A - Blue Star Foods Corp. (0001730773) (Subject)

    11/14/24 7:34:10 PM ET
    $BSFC

    Amendment: SEC Form SC 13G/A filed by GSE Systems Inc.

    SC 13G/A - GSE SYSTEMS INC (0000944480) (Subject)

    11/14/24 7:13:40 PM ET
    $GVP
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Avalo Therapeutics Inc.

    SC 13G - Avalo Therapeutics, Inc. (0001534120) (Subject)

    11/14/24 6:23:00 PM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care